BioDuro-Sundia's customized fragment library of 2,300 compounds includes nearly 50% internally synthesized that are not covered by commercial fragments, which provides differentiated value and enhances the probability of identifying truly novel hits
Chemical structures of fragment hits are disclosed to clients who are offered full freedom to operate
Transparent cost structure, no downstream financial obligations
Deep expertise in SPR and in the entire process of FBDD
Advanced DNA-encoded library (DEL) small molecule drug discovery screening services
BioDuro-Sundia and X-Chem have partnered to provide DEL services since August 2022
High quality lead-like/drug-like focused libraries incorporating state-of-the-art DEL design and synthesis
Thorough protein QC and AI-powered comprehensive DEL selection data analysis
Hit structures with embedded SAR information provided to clients who are offered full freedom to operate
Transparent cost structure, no downstream financial obligations
Unmatched track record for DEL-driven hit identification by X-Chem, backed by comprehensive Discovery services (Chemistry, Biology, DMPK, Pharmacology) by BioDuro-Sundia to rapidly advance clients’ discovery programs
Home
